Approximately 20–25% of traumatic brain injury (TBI) subjects develop acute lung injury (ALI), but the pathomechanisms of TBI-induced ALI remain poorly defined. Our previous work has shown that the inflammasome plays a critical role in TBI-induced secondary pathophysiology and that inflammasome proteins are released in extracellular vesicles (EV) after TBI. Here we investigated whether EV-mediated inflammasome signaling contributed to the etiology of TBI-induced ALI. C57/BL6 male mice were subjected to controlled cortical impact (CCI), and the brains and lungs were examined for inflammasome activation and ALI at 4 and 24 h after TBI. We show that TBI releases EV containing inflammasome proteins into serum that target the lung to cause ALI, supporting activation of a neural-respiratory-inflammasome axis. Administration of a low-molecular-weight heparin (enoxaparin, a blocker of EV uptake) or treatment with a monoclonal antibody against apoptosis speck-like staining protein containing a caspase recruitment domain (anti-ASC) after adoptive transfer of EV isolated from TBI-injured mice significantly inhibited inflammasome activation in the lungs of recipient mice resulting in improved ALI scores.This axis constitutes an important arm of the innate inflammatory response in lung pathology after TBI and targeting this axis represents a novel therapeutic treatment for TBI-induced ALI.
Get full access to this article
View all access options for this article.
References
1.
SummersC.R., IvinsB., and SchwabK.A. (2009). Traumatic brain injury in the United States: an epidemiologic overview. Mt. Sinai J. Med., 76, 105–110.
2.
BramlettH.M., and DietrichW.D. (2015). Long-term consequences of traumatic brain injury: current status of potential mechanisms of injury and neurological outcomes. J. Neurotrauma, 32, 1834–1848.
3.
ChovatiyaR., and MedzhitovR. (2014). Stress, inflammation, and defense of homeostasis. Mol. Cell, 54, 281–288.
4.
NewtonK., and DixitV.M. (2012). Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Bio. 4. pii: a006049.
5.
de Rivero VaccariJ.P., DietrichW.D., and KeaneR.W. (2014). Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J. Cereb. Blood Flow Metab., 34, 369–375.
6.
Fernandes-AlnemriT., and AlnemriE.S. (2008). Assembly, purification, and assay of the activity of the ASC pyroptosome. Methods Enzymol. 442, 251–270.
7.
NicollsM.R., and LaubachV.E. (2014). Traumatic brain injury: lungs in a RAGE. Sci. Transl. Med., 6, 252fs234.
8.
YadavH., NolanM.E., BohmanJ.K., Cartin-CebaR., PetersS.G., HoganW.J., GajicO., and KorD.J. (2016). Epidemiology of acute respiratory distress syndrome following hematopoietic stem cell transplantation. Crit. Care Med., 44, 1082–1090.
9.
RinconF., GhoshS., DeyS., MaltenfortM., VibbertM., UrtechoJ., McBrideW., MoussouttasM., BellR., RatliffJ.K., and JalloJ. (2012). Impact of acute lung injury and acute respiratory distress syndrome after traumatic brain injury in the United States. Neurosurgery, 71, 795–803.
10.
AnderssonU., and RauvalaH. (2011). Introduction: HMGB1 in inflammation and innate immunity. J. Intern. Med., 270, 296–300.
11.
FeldmanP., DueM.R., RipschM.S., KhannaR., and WhiteF.A. (2012). The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. J. Neuroinflammation, 9, 180.
SunQ., LoughranP., ShapiroR., ShrivastavaI.H., AntoineD.J., LiT., YanZ., FanJ., BilliarT.R., and ScottM.J. (2017). Redox-dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice. Hepatology, 65, 253–268.
14.
LuB., NakamuraT., InouyeK., LiJ., TangY., LundbackP., Valdes-FerrerS.I., OlofssonP.S., KalbT., RothJ., ZouY., Erlandsson-HarrisH., YangH., TingJ.P., WangH., AnderssonU., AntoineD.J., ChavanS.S., HotamisligilG.S., and TraceyK.J. (2012). Novel role of PKR in inflammasome activation and HMGB1 release. Nature, 488, 670–674.
15.
WareL.B., and MatthayM.A. (2000). The acute respiratory distress syndrome. N. Engl. J. Med., 342, 1334–1349.
16.
Yanez-MoM., SiljanderP.R., AndreuZ., ZavecA.B., BorrasF.E., BuzasE.I., BuzasK., CasalE., CappelloF., CarvalhoJ., ColasE., Cordeiro-da SilvaA., FaisS., Falcon-PerezJ.M., GhobrialI.M., GiebelB., GimonaM., GranerM., GurselI., GurselM., HeegaardN.H., HendrixA., KierulfP., KokubunK., KosanovicM., Kralj-IglicV., Kramer-AlbersE.M., LaitinenS., LasserC., LenerT., LigetiE., LineA., LippsG., LlorenteA., LotvallJ., Mancek-KeberM., MarcillaA., MittelbrunnM., NazarenkoI., Nolte-'t HoenE.N., NymanT.A., O'DriscollL., OlivanM., OliveiraC., PallingerE., Del PortilloH.A., ReventosJ., RigauM., RohdeE., SammarM., Sanchez-MadridF., SantaremN., SchallmoserK., OstenfeldM.S., StoorvogelW., StukeljR., Van der GreinS.G., VasconcelosM.H., WaubenM.H., and De WeverO. (2015). Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles, 4, 27066.
17.
BuzasE.I., GyorgyB., NagyG., FalusA., and GayS. (2014). Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol., 10, 356–364.
18.
QuY., FranchiL., NunezG., and DubyakG.R. (2007). Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol., 179, 1913–1925.
19.
de Rivero VaccariJ.P., BrandF.3rd, AdamczakS., LeeS.W., BarcenaJ.P., WangM.Y., BullockM.R., DietrichW.D., and KeaneR.W. (2015). Exosome-mediated inflammasome signaling after central nervous system injury. J. Neurochem., 136, Suppl. 1, 39–48.
20.
AtaiN.A., BalajL., van VeenH., BreakefieldX.O., JarzynaP.A., Van NoordenC.J., SkogJ., and MaguireC.A. (2013). Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J. Neurooncol., 115, 343–351.
21.
de Rivero VaccariJ.P., LotockiG., MarcilloA.E., DietrichW.D., and KeaneR.W. (2008). A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci., 28, 3404–3414.
22.
Assis-NascimentoP., UmlandO., CeperoM.L., and LieblD.J. (2016). A flow cytometric approach to analyzing mature and progenitor endothelial cells following traumatic brain injury. J. Neurosci. Methods, 263, 57–67.
23.
XiongY., MahmoodA., and ChoppM. (2013). Animal models of traumatic brain injury. Nat. Rev. Neurosci., 14, 128–142.
24.
CampoloM., EspositoE., and CuzzocreaS. (2018). A controlled cortical impact preclinical model of traumatic brain injury. Methods Mol. Biol., 1727, 385–391.
25.
Kokiko-CochranO.N., SaberM., PuntambekarS., BemillerS.M., KatsumotoA., LeeY.S., BhaskarK., RansohoffR.M., and LambB.T. (2017). Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery. J Neurotrauma, 35, 73–84.
26.
AtkinsC.M., CeperoM.L., KangY., LieblD.J., and DietrichW.D. (2013). Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice. Neurosci. Lett., 532, 1–6.
27.
WuS., PlatteauA., ChenS., McNamaraG., WhitsettJ., and BancalariE. (2010). Conditional overexpression of connective tissue growth factor disrupts postnatal lung development. Am. J. Respir. Cell Mol. Biol., 42, 552–563.
28.
WiklanderO.P., NordinJ.Z., O'LoughlinA., GustafssonY., CorsoG., MagerI., VaderP., LeeY., SorkH., SeowY., HeldringN., Alvarez-ErvitiL., SmithC.I., Le BlancK., MacchiariniP., JungebluthP., WoodM.J., and AndaloussiS.E. (2015). Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles, 4, 26316.
29.
Matute-BelloG., DowneyG., MooreB.B., GroshongS.D., MatthayM.A., SlutskyA.S., KueblerW.M., and Acute Lung Injury in Animals StudyGroup. (2011). An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol., 44, 725–738.
30.
de Rivero VaccariJ.P., LotockiG., AlonsoO.F., BramlettH.M., DietrichW.D., and KeaneR.W. (2009). Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J. Cereb. Blood Flow Metab., 29, 1251–1261.
31.
RagallerM., and RichterT. (2010). Acute lung injury and acute respiratory distress syndrome. J. Emerg. Trauma Shock, 3, 43–51.
32.
HendricksonC.M., HowardB.M., KornblithL.Z., ConroyA.S., NelsonM.F., ZhuoH., LiuK.D., ManleyG., MatthayM.A., CalfeeC.S., and CohenM.J. (2016). The acute respiratory distress syndrome following isolated severe traumatic brain injury. J. Trauma Acute Care Surg., 80, 989–997.
33.
MasciaL. (2009). Acute lung injury in patients with severe brain injury: a double hit model. Neurocrit. Care, 11, 417–426.
34.
CrossL.J., and MatthayM.A. (2011). Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury. Crit. Care Clin., 27, 355–377.
35.
LuhS.P., and ChiangC.H. (2007). Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies. J. Zhejiang Univ. Sci. B, 8, 60–69.
LiuX., ZhangZ., RuanJ., PanY., MagupalliV.G., WuH., and LiebermanJ. (2016). Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature, 535, 153–158.
38.
KalsotraA., ZhaoJ., AnakkS., DashP.K., and StrobelH.W. (2007). Brain trauma leads to enhanced lung inflammation and injury: evidence for role of P4504Fs in resolution. J. Cereb. Blood Flow Metab., 27, 963–974.
PeltzE.D., MooreM.E., EckelsP.C., DamleS.S., TsurutaY., JohnsonJ.L., SauaiaA., SillimanC.C., BanerjeeA., and AbrahamE. (209). HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock, 32, 17–22.
41.
ZygunD.A., KortbeekJ.B., FickG.H., LauplandK.B., and DoigC.J. (2005). Non-neurologic organ dysfunction in severe traumatic brain injury. Crit. Care Med., 33, 654–660.
42.
Hay (2015). Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans. J. Neuropathol. Exp. Neurol., 74, 1147–1157.
43.
MrozekS., DumurgierJ., CiterioG., MebazaaA., and GeeraertsT. (2014). Biomarkers and acute brain injuries: interest and limits. Crit. Care, 18, 220.
44.
SpectorR., Robert SnodgrassS., and JohansonC.E. (2015). A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Exp. Neurol., 273, 57–68.
45.
MulcahyL.A., PinkR.C., and CarterD.R. (2014). Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles. 3.
46.
TyrrellD.J., HorneA.P., HolmeK.R., PreussJ.M., and PageC.P. (1999). Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv. Pharmacol., 46, 151–208.
47.
CampoC., MolinariJ.F., UngoJ., and AhmedT. (1999). Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses. J. Appl. Physiol. (1985)86, 549–557.
48.
LuanZ.G., NaranpurevM., and MaX.C. (2014). Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Inflammation, 37, 924–932.
49.
NingF., WangX., ShangL., WangT., LvC., QiZ., and WuD. (2015). Low molecular weight heparin may prevent acute lung injury induced by sepsis in rats. Gene, 557, 88–91.
50.
ShomerE., KatzenellS., ZiporiY., Rebibo-SabbahA., BrennerB., and AharonA. (2016). Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function. Thromb. Res., 137, 141–147.
51.
SustarV., JansaR., FrankM., HagerstrandH., KrzanM., IglicA., and Kralj-IglicV. (2009). Suppression of membrane microvesiculation—a possible anticoagulant and anti-tumor progression effect of heparin. Blood Cells Mol. Dis., 42, 223–227.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
